|
|
Biochem J. 2000 September 15; 350(Pt 3): 823–828. | PMCID: PMC1221316 |
Functional and molecular modelling studies of two hereditary fructose intolerance-causing mutations at arginine 303 in human liver aldolase. R Santamaria, G Esposito, L Vitagliano, V Race, I Paglionico, L Zancan, A Zagari, and F Salvatore Dipartimento di Biochimica e Biotecnologie Mediche, CEINGE-Biotecnologie Avanzate, Università di Napoli 'Federico II', Via S. Pansini 5, I-80131, Napoli, Italy. We have identified a novel hereditary fructose intolerance mutation in the aldolase B gene (i.e. liver aldolase) that causes an arginine-to-glutamine substitution at residue 303 (Arg(303)-->Gln). We previously described another mutation (Arg(303)-->Trp) at the same residue. We have expressed the wild-type protein and the two mutated proteins and characterized their kinetic properties. The catalytic efficiency of protein Gln(303) is approx. 1/100 that of the wild-type for substrates fructose 1,6-bisphosphate and fructose 1-phosphate. The Trp(303) enzyme has a catalytic efficiency approx. 1/4800 that of the wild-type for fructose 1,6-bisphosphate; no activity was detected with fructose 1-phosphate. The mutation Arg(303)-->Trp thus substitution impairs enzyme activity more than Arg(303)-->Gln. Three-dimensional models of wild-type, Trp(303) and Gln(303) aldolase B generated by homology-modelling techniques suggest that, because of its larger size, tryptophan exerts a greater deranging effect than glutamine on the enzyme's three-dimensional structure. Our results show that the Arg(303)-->Gln substitution is a novel mutation causing hereditary fructose intolerance and provide a functional demonstration that Arg(303), a conserved residue in all vertebrate aldolases, has a dominant role in substrate binding during enzyme catalysis. The Full Text of this article is available as a PDF (224K). These references are in PubMed. This may not be the complete list of references from this article. - Salvatore F, Izzo P, Paolella G. Aldolase gene and protein families: structure, expression and pathophysiology. Horiz Biochem Biophys. 1986;8:611–665. [PubMed]
- Ali M, Rellos P, Cox TM. Hereditary fructose intolerance. J Med Genet. 1998 May;35(5):353–365. [PubMed]
- Santamaria R, Scarano MI, Esposito G, Chiandetti L, Izzo P, Salvatore F. The molecular basis of hereditary fructose intolerance in Italian children. Eur J Clin Chem Clin Biochem. 1993 Oct;31(10):675–678. [PubMed]
- Santamaria R, Tamasi S, Del Piano G, Sebastio G, Andria G, Borrone C, Faldella G, Izzo P, Salvatore F. Molecular basis of hereditary fructose intolerance in Italy: identification of two novel mutations in the aldolase B gene. J Med Genet. 1996 Sep;33(9):786–788. [PubMed]
- Santamaria R, Vitagliano L, Tamasi S, Izzo P, Zancan L, Zagari A, Salvatore F. Novel six-nucleotide deletion in the hepatic fructose-1,6-bisphosphate aldolase gene in a patient with hereditary fructose intolerance and enzyme structure-function implications. Eur J Hum Genet. 1999 May–Jun;7(4):409–414. [PubMed]
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215. [PubMed]
- Paolella G, Santamaria R, Izzo P, Costanzo P, Salvatore F. Isolation and nucleotide sequence of a full-length cDNA coding for aldolase B from human liver. Nucleic Acids Res. 1984 Oct 11;12(19):7401–7410. [PubMed]
- Morris AJ, Tolan DR. Site-directed mutagenesis identifies aspartate 33 as a previously unidentified critical residue in the catalytic mechanism of rabbit aldolase A. J Biol Chem. 1993 Jan 15;268(2):1095–1100. [PubMed]
- Cregut D, Serrano L. Molecular dynamics as a tool to detect protein foldability. A mutant of domain B1 of protein G with non-native secondary structure propensities. Protein Sci. 1999 Feb;8(2):271–282. [PubMed]
- Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. [PubMed]
- Doyle SA, Tolan DR. Characterization of recombinant human aldolase B and purification by metal chelate chromatography. Biochem Biophys Res Commun. 1995 Jan 26;206(3):902–908. [PubMed]
- Gamblin SJ, Davies GJ, Grimes JM, Jackson RM, Littlechild JA, Watson HC. Activity and specificity of human aldolases. J Mol Biol. 1991 Jun 20;219(4):573–576. [PubMed]
- Blom N, Sygusch J. Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase. Nat Struct Biol. 1997 Jan;4(1):36–39. [PubMed]
- Choi KH, Mazurkie AS, Morris AJ, Utheza D, Tolan DR, Allen KN. Structure of a fructose-1,6-bis(phosphate) aldolase liganded to its natural substrate in a cleavage-defective mutant at 2.3 A(,). Biochemistry. 1999 Sep 28;38(39):12655–12664. [PubMed]
- Wang J, Morris AJ, Tolan DR, Pagliaro L. The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants. J Biol Chem. 1996 Mar 22;271(12):6861–6865. [PubMed]
|